首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Obstetric and neonatal outcome in pregnancies complicated by hemolysis elevated liver enzymes low platelet count syndrome at a tertiary care centre in India
【24h】

Obstetric and neonatal outcome in pregnancies complicated by hemolysis elevated liver enzymes low platelet count syndrome at a tertiary care centre in India

机译:印度一家三级医疗中心的孕妇产科和新生儿结局并发溶血,肝酶升高,血小板计数低综合征

获取原文
           

摘要

Background: The hemolysis elevated liver enzymes low platelet count (HELLP) syndrome is a serious complication in pregnancy characterized by hemolysis, elevated liver enzymes and low platelet count occurring in 0.4 to 0.7% of all pregnancies and in 10-12% of cases with severe preeclampsia. This present study will throw some light on occurrence, diagnosis, complications, treatment, mode of delivery and the neonatal outcome. Methods: A prospective observational study was conducted in the department of Obstetrics and Gynecology at Seth G.S. Medical College and KEM hospital which is a tertiary care centre in Mumbai in the state of Maharashtra India from September 2013 to December 2014 after the approval of institutional ethics committee. The inclusion criteria were only those patients in whom HELLP syndrome was diagnosed on the basis of blood investigations, laboratory parameters and clinical picture. All those patients who did not fulfill the diagnostic criteria for HELLP syndrome were excluded. Results: In our study, according to the Mississippi classification, 15% belonged to class 1, 62% to class 2 and 23% to class 3. The peak age of incidence was 21-30 years (78%) and majority were primigravida (57%). Majority (91%) presented with headache and the other associated complains were epigastric pain, nausea, vomiting and blurring of vision. Only 32% patients presented at term (>37 weeks), 65% patients were at 28-36 weeks of gestation and 3% had very early onset HELLP syndrome. Majority (65%) had severe hypertension (BP>160/110 mm of Hg) with albuminuria of grade +3 to +4. Majority (83%) of the patients were given injection MgSO4 either for prophylaxis or treatment of eclampsia. 65% patients delivered vaginally. 70% were live births, out of which 8% died in the early neonatal period. Severe maternal complications such as eclampsia, hematuria, acute kidney injury, abruption placentae, severe anemia and DIC were seen in 63% patients. 57% of patients were transfused with blood and blood products and 7% required intensive care management. Conclusions: A multidisciplinary approach is of utmost importance along with early diagnosis and prompt treatment to prevent the cataclysmic deterioration of patients with HELLP syndrome.
机译:背景:溶血性肝酶低血小板计数升高(HELLP)综合征是妊娠期间的严重并发症,其特征是溶血,肝酶升高和低血小板计数发生在所有妊娠的0.4%至0.7%以及重症患者的10-12%子痫前期。本研究将阐明发生,诊断,并发症,治疗,分娩方式和新生儿结局。方法:2013年9月至2014年12月,经机构伦理委员会批准,在印度马哈拉施特拉邦孟买的三级护理中心塞斯·GS医学院和KEM医院的妇产科进行了前瞻性观察研究。 。入选标准仅是根据血液检查,实验室参数和临床图像诊断为HELLP综合征的患者。排除所有不符合HELLP综合征诊断标准的患者。结果:在我们的研究中,根据密西西比州分类,15%属于1级,62%属于2级,23%属于3级。最高发病年龄为21-30岁(78%),多数为初产妇( 57%)。多数(91%)表现为头痛,其他相关的抱怨是上腹痛,恶心,呕吐和视力模糊。在足月(> 37周)出现的患者只有32%,在妊娠28-36周时出现的患者为65%,并且有非常早发的HELLP综合征。多数(65%)患有严重高血压(BP> 160/110 mm Hg),蛋白尿为+3至+4级。绝大多数(83%)患者注射了MgSO4注射液以预防或治疗子痫。 65%的患者通过阴道分娩。 70%是活产,其中8%在新生儿早期死亡。在63%的患者中发现了严重的产妇并发症,如子痫,血尿,急性肾损伤,胎盘早剥,严重贫血和DIC。 57%的患者输了血液和血液制品,而7%的患者需要重症监护。结论:多学科方法对早期诊断和及时治疗至关重要,以防止HELLP综合征患者的催化恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号